Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

106 CEFTAZIDIME
(1994): Pleasants RA+, Chest 106, 1124 (in patients with cystic
fibrosis)
Angioedema (2%)
Diaper rash
Diaphoresis
Edema
Erythema multiforme (2%)
(1983): Pierce TH+, J Antimicrob Chemother 12 (Suppl A), 21
Exanthems
(1985): Richards DM+, Drugs 29, 105 (1.6%)
Pemphigus erythematodes
(1993): Iannantuono M+, Int J Dermatol 32, 675
(1993): Pellicano R+, Int J Dermatol 32, 675
Photosensitivity
(1993): Vinks SA+, Lancet 341, 1221
Pruritus (2%)
(1996): Holloway WJ+, Am J Med 100, 52S
(1985): Richards DM+, Drugs 29, 105
Rash (sic) (2%)
(2001): Mustafa MM+, Pediatr Infect Dis J 20(3), 362
(2000): Fang CT+, Chemotherapy 46(5), 371
(2000): Feld R+, J Clin Oncol 18(21), 3690
(1996): Holloway WJ+, Am J Med 100, 52S
Stevens–Johnson syndrome (2%)
Toxic epidermal necrolysis (2%)
(2000): Thestrup-Pedersen K+, Acta Derm Venereol 80(4), 316
(with vancomycin)
Toxic erythema
(1995): Rademaker M, NZMedJ108, 165
Toxic pustuloderma
(1990): Rustin MHA+, Br J Dermatol 123, 119
Urticaria (